MetLife (MET) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

07.05.26 00:30 Uhr

Werte in diesem Artikel
Aktien

73,26 EUR -1,62 EUR -2,16%

Indizes

PKT PKT

19.171,9 PKT -36,6 PKT -0,19%

3.667,3 PKT 31,2 PKT 0,86%

7.499,4 PKT 58,9 PKT 0,79%

MetLife (MET) reported $19.68 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 4.5%. EPS of $2.42 for the same period compares to $1.96 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $19.22 billion, representing a surprise of +2.4%. The company delivered an EPS surprise of +7.54%, with the consensus EPS estimate being $2.25.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how MetLife performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Institutional Client AUM: $313.16 billion compared to the $327.51 billion average estimate based on three analysts.Total AUM: $736.29 billion versus $712.22 billion estimated by three analysts on average.METLIFE INVESTMENT MANAGEMENT(MIM)-GA AUM: $423.13 billion versus the three-analyst average estimate of $384.71 billion.Adjusted Revenue- Corporate & other- Net investment income: $953 million compared to the $1.09 billion average estimate based on three analysts. The reported number represents a change of +1242.3% year over year.Adjusted Revenue- Corporate & other- Premiums: $592 million versus $652.83 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +6477.8% change.Adjusted Revenue- EMEA- Net investment income: $67 million versus the three-analyst average estimate of $66.84 million. The reported number represents a year-over-year change of +15.5%.Adjusted Revenue- Latin America- Net investment income: $409 million versus the three-analyst average estimate of $457.71 million. The reported number represents a year-over-year change of +0.5%.Revenue- Other Revenues: $852 million compared to the $705.49 million average estimate based on four analysts. The reported number represents a change of +24% year over year.Revenue- Net investment income: $5.36 billion compared to the $5.71 billion average estimate based on four analysts. The reported number represents a change of +9.6% year over year.Revenue- Universal life and investment-type product policy fees: $1.34 billion compared to the $1.29 billion average estimate based on four analysts. The reported number represents a change of +9.3% year over year.Revenue- Premiums: $12.12 billion compared to the $11.49 billion average estimate based on four analysts. The reported number represents a change of +3.4% year over year.Total Adjusted Revenue- Group Benefits: $6.89 billion versus the three-analyst average estimate of $6.92 billion. The reported number represents a year-over-year change of +2.2%.View all Key Company Metrics for MetLife here>>>Shares of MetLife have returned +12.2% over the past month versus the Zacks S&P 500 composite's +10.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>This article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: MetLife und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Quelle: Zacks

Nachrichten zu MetLife Inc.

Analysen zu MetLife Inc.

DatumRatingAnalyst
02.01.2018MetLife HoldDeutsche Bank AG
03.11.2017MetLife OutperformRBC Capital Markets
25.05.2017MetLife OutperformFBR & Co.
09.12.2016MetLife HoldStandpoint Research
28.11.2016MetLife Mkt PerformFBR & Co.
DatumRatingAnalyst
03.11.2017MetLife OutperformRBC Capital Markets
25.05.2017MetLife OutperformFBR & Co.
05.05.2016MetLife OutperformRBC Capital Markets
31.07.2015MetLife BuyDeutsche Bank AG
22.06.2015MetLife OutperformRBC Capital Markets
DatumRatingAnalyst
02.01.2018MetLife HoldDeutsche Bank AG
09.12.2016MetLife HoldStandpoint Research
28.11.2016MetLife Mkt PerformFBR & Co.
13.07.2016MetLife HoldDeutsche Bank AG
15.03.2016MetLife NeutralUBS AG
DatumRatingAnalyst
04.12.2006Update MetLife Inc.: UnderperformFriedman, Billings Ramsey & Co
14.09.2005MetLife DowngradeDeutsche Securities
14.09.2005Update MetLife Inc.: SellDeutsche Securities

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für MetLife Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen